ShareHope Medicine Co., Ltd.

Total Valuation

ShareHope Medicine Co., Ltd. carries a market capitalization of 2.70B, placing it among publicly traded companies globally. Its enterprise value stands at 3.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

ShareHope Medicine Co., Ltd. currently has 137.64M shares outstanding.

Valuation Ratios

ShareHope Medicine Co., Ltd. trades at a trailing price-to-earnings ratio of 21.91. The price-to-sales ratio is 0.71, and the price-to-book ratio stands at 1.42.

Enterprise Valuation

On an enterprise value basis, ShareHope Medicine Co., Ltd. trades at an EV/EBITDA multiple of 21.19 and an EV/FCF ratio of 6.99. The EV/Sales ratio of 0.85 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.19 provides insight into valuation relative to core operating earnings.

Financial Position

ShareHope Medicine Co., Ltd. maintains a current ratio of 2.00, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 46.93, indicating elevated leverage, while an interest coverage ratio of 3.67 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

ShareHope Medicine Co., Ltd. posts a return on equity of 6.56 and a return on invested capital of 2.24.

Taxes

Over the trailing twelve months, ShareHope Medicine Co., Ltd. has paid 38.25M in income taxes, reflecting an effective tax rate of 25.48.

Stock Price Statistics

ShareHope Medicine Co., Ltd.'s stock has declined approximately -23.30211% over the past 52 weeks. The 50-day moving average sits at 20.02, while the 200-day moving average is 22.73.

Income Statement

Over the trailing twelve months, ShareHope Medicine Co., Ltd. generated 4.36B in revenue and converted that into 141.73M in net income, yielding earnings per share of 0.81. EBITDA reached 175.28M, while operating income came in at 175.28M.

Balance Sheet

ShareHope Medicine Co., Ltd. holds 1.58B in cash and equivalents against 1.80B in total debt, resulting in a net debt position of -8.77M. Total book value stands at 2.19B, with working capital of 1.57B providing operational flexibility.

Cash Flow

ShareHope Medicine Co., Ltd. produced 364.13M in operating cash flow over the past twelve months. After subtracting -131.81M in capital expenditures, free cash flow totaled 232.32M - equivalent to 1.75 per share.

Margins

ShareHope Medicine Co., Ltd. operates with a gross margin of 16.27, reflecting its pricing power and cost economics. The operating margin of 4.02 and net profit margin of 3.25 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

ShareHope Medicine Co., Ltd.'s most recent stock split took place on August 26, 2025 with a 20:21 split ratio.

Scores

ShareHope Medicine Co., Ltd. posts an Altman Z-Score of 1.93, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.